These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8273581)
1. Effect of 5-lipoxygenase inhibitors on in situ LTB4 biosynthesis following calcium ionophore stimulation in the rat pleural cavity. Raychaudhuri A; Chertock H; Peppard J; White WD; Koeler J; DiPasquale G Agents Actions; 1993; 39 Spec No():C43-5. PubMed ID: 8273581 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of LTB4 biosynthesis in situ by CGS 23885, a potent 5-lipoxygenase inhibitor, correlates with its pleural fluid concentrations in an experimentally induced rat pleurisy model. Raychaudhuri A; Chertock H; Chovan J; Jones LS; Kimble EF; Kowalski TJ; Peppard J; White DH; Satoh Y; Roland D Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):470-4. PubMed ID: 9109363 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of leukotriene B4 biosynthesis by disulfiram and A-64077 during carrageenan-induced pleurisy in the rat. Riendeau D; Guay J; Foster A; Wolfe S; Chan CC Gen Pharmacol; 1991; 22(2):371-4. PubMed ID: 1647348 [TBL] [Abstract][Full Text] [Related]
5. Effect of BI-L-239, A-64077 and MK-886 on leukotriene B4 synthesis by chopped guinea pig lung and on antigen-induced tracheal contraction in vitro. Noonan TC; Jamieson-Leclercq T; Desai SN Prostaglandins; 1992 Dec; 44(6):543-54. PubMed ID: 1335586 [TBL] [Abstract][Full Text] [Related]
6. Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors. Bell RL; Bouska JB; Malo PE; Lanni C; Harris RR; Otis ER; Stewart AO; Brooks DW; Carter GW J Pharmacol Exp Ther; 1995 Feb; 272(2):724-31. PubMed ID: 7853186 [TBL] [Abstract][Full Text] [Related]
7. A23187 stimulates translocation of 5-lipoxygenase from cytosol to membrane in human alveolar macrophages. Pueringer RJ; Bahns CC; Monick MM; Hunninghake GW Am J Physiol; 1992 Apr; 262(4 Pt 1):L454-8. PubMed ID: 1314503 [TBL] [Abstract][Full Text] [Related]
8. 5-lipoxygenase inhibitory activity of zileuton. Carter GW; Young PR; Albert DH; Bouska J; Dyer R; Bell RL; Summers JB; Brooks DW J Pharmacol Exp Ther; 1991 Mar; 256(3):929-37. PubMed ID: 1848634 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of fenleuton, a 5-lipoxygenase inhibitor, in ponies. Marr K; Marsh K; Hernandez L; Cunningham FM; Lees P Res Vet Sci; 1998; 64(2):111-7. PubMed ID: 9625466 [TBL] [Abstract][Full Text] [Related]
11. Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole blood ex vivo. Sirois P; Borgeat P; Lauzière M; Dubé L; Rubin P; Kesterson J Agents Actions; 1991 Sep; 34(1-2):117-20. PubMed ID: 1665285 [TBL] [Abstract][Full Text] [Related]
12. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models. Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987 [TBL] [Abstract][Full Text] [Related]
13. Lyprinol inhibits LTB4 production by human monocytes. Dugas B Allerg Immunol (Paris); 2000 Sep; 32(7):284-9. PubMed ID: 11094642 [TBL] [Abstract][Full Text] [Related]
14. Pharmacology of the 5-lipoxygenase inhibitors BAY Y 1015 and BAY X 1005 in the horse. Cunningham FM; Andrews M; Landoni MF; Lees P J Vet Pharmacol Ther; 1997 Aug; 20(4):296-307. PubMed ID: 9280370 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the in vivo biochemical efficacy of orally active leukotriene biosynthesis inhibitors. Tagari P; Brideau C; Chan C; Frenette R; Black C; Ford-Hutchinson A Agents Actions; 1993 Sep; 40(1-2):62-71. PubMed ID: 8147271 [TBL] [Abstract][Full Text] [Related]
16. The production of 5-HETE and leukotriene B in rat neutrophils from carrageenan pleural exudates. Siegel MI; McConnell RT; Bonser RW; Cuatrecasas P Prostaglandins; 1981 Jan; 21(1):123-32. PubMed ID: 6259697 [TBL] [Abstract][Full Text] [Related]
17. CGS 22745: a selective orally active inhibitor of 5-lipoxygenase. Kimble E; Kowalski T; White D; Raychauduri A; Pastor G; Chertock H; Lee W; Neale R; Hamdan A; Wasley J Agents Actions; 1991 Sep; 34(1-2):125-8. PubMed ID: 1665286 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of 5-lipoxygenase inhibitors, zileuton, A-78773 and ICI-D-2138 in an ionophore (A-23187)-induced pleural inflammation model in the rat. Rao TS; Currie JL; Shaffer AF; Isakson PC Life Sci; 1993; 53(9):PL147-52. PubMed ID: 8394967 [TBL] [Abstract][Full Text] [Related]
20. Leukocyte recruitment in the subcutaneous sponge implant model of acute inflammation in the rat is not mediated by leukotriene B1. Foster SJ; McCormick ME; Howarth A; Aked D Biochem Pharmacol; 1986 May; 35(10):1709-17. PubMed ID: 3011012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]